NO164417C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater.

Info

Publication number
NO164417C
NO164417C NO851638A NO851638A NO164417C NO 164417 C NO164417 C NO 164417C NO 851638 A NO851638 A NO 851638A NO 851638 A NO851638 A NO 851638A NO 164417 C NO164417 C NO 164417C
Authority
NO
Norway
Prior art keywords
iminothiazolide
ingredients
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO851638A
Other languages
English (en)
Norwegian (no)
Other versions
NO851638L (no
NO164417B (no
Inventor
Karoly Lempert
Gyula Hornyak
Ferenc Bartha
Gabor Doleschall
Jozsef Fetter
Jozsef Nyitrai
Gyula Simig
Karoly Zauer
Peter Huszthy
Antal Feller
Lujza Petocz
Eniko Szirt
Katalin Grasser
Edit Berenyi
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of NO851638L publication Critical patent/NO851638L/no
Publication of NO164417B publication Critical patent/NO164417B/no
Publication of NO164417C publication Critical patent/NO164417C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO851638A 1984-04-25 1985-04-24 Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater. NO164417C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU841581A HU191408B (en) 1984-04-25 1984-04-25 Process for preparing new imino-thiazolidine derivatives

Publications (3)

Publication Number Publication Date
NO851638L NO851638L (no) 1985-10-28
NO164417B NO164417B (no) 1990-06-25
NO164417C true NO164417C (no) 1990-10-10

Family

ID=10955127

Family Applications (1)

Application Number Title Priority Date Filing Date
NO851638A NO164417C (no) 1984-04-25 1985-04-24 Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater.

Country Status (24)

Country Link
US (1) US4665083A (pl)
JP (1) JPS6127974A (pl)
AT (1) AT394555B (pl)
BE (1) BE902249A (pl)
CA (1) CA1246086A (pl)
CH (1) CH664564A5 (pl)
CS (1) CS255884B2 (pl)
DD (1) DD231790A5 (pl)
DE (1) DE3514843A1 (pl)
DK (1) DK183585A (pl)
ES (3) ES8608499A1 (pl)
FI (1) FI82454C (pl)
FR (1) FR2563519B1 (pl)
GB (1) GB2159814B (pl)
GR (1) GR851006B (pl)
HU (1) HU191408B (pl)
IT (1) IT1208532B (pl)
NL (1) NL8501184A (pl)
NO (1) NO164417C (pl)
PH (1) PH20995A (pl)
PL (3) PL144860B1 (pl)
PT (1) PT80336B (pl)
SE (1) SE464813B (pl)
SU (3) SU1366058A3 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3442757A1 (de) * 1984-11-23 1986-05-28 Wella Ag, 6100 Darmstadt Verwendung von 2-nitroanilinderivaten in haarfaerbemitteln und neue 2-nitroanilinderivate
US4867782A (en) * 1988-07-01 1989-09-19 Ici Americas Inc. Novel herbicidal 2-sulfonyliminothiazolidines
US5266701A (en) * 1988-07-01 1993-11-30 Ici Americas Inc. Process for production of 2-iminothiazolidines and oxazolidines
CA2063865A1 (en) * 1992-03-24 1993-09-25 Karoly Lempert 2-(substituted imino)-thiazolidines and process for the preparation thereof
US5463069A (en) * 1992-12-04 1995-10-31 Sumitomo Chemical Company, Limited Process of producing 2-iminothiazoline derivatives and process of producing their intermediates
WO2007010281A2 (en) * 2005-07-21 2007-01-25 Betagenon Ab Use of thiazole derivatives and analogues in disorders caused by free fatty acids
WO2010086613A1 (en) 2009-01-30 2010-08-05 Betagenon Ab Compounds useful as inhibitors as ampk
BR112015031155A2 (pt) 2013-06-20 2017-07-25 Bayer Cropscience Ag derivados de sulfureto de arila e derivados de aril sulfóxido como acaricidas e inseticidas

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB690238A (en) * 1949-08-23 1953-04-15 Knoll Ag Process of producing 3, 4-dimethyl-5-phenyl-2-iminothiazolidine
DE841149C (de) * 1949-11-01 1952-06-13 Knoll Ag Verfahren zur Herstellung von 3, 4-Dimethyl-5-phenyl-2-iminothiazolidin
DE910650C (de) * 1951-09-14 1954-05-03 Knoll Ag Verfahren zur Herstellung von 2-Amino-í¸ -thiazolinen bzw. Thiazolidon-(2)-imiden undderen Salzen
US3297708A (en) * 1965-10-06 1967-01-10 American Cyanamid Co Method of preparing thiazolidines
FR1510014A (fr) * 1966-12-05 1968-01-19 Aquitaine Petrole Préparation de dithiolannes
SU465792A3 (ru) * 1968-11-06 1975-03-30 Хиноин Гиогисцер-Ес Вегиесцети Термекек Гиара Рт (Фирма) Способ получени гетероциклических соединений
US3671537A (en) * 1969-06-05 1972-06-20 Gyogyszerkutato Intezet Certain 3-(2,6-dichlorophenyl)-2-iminothiazolidines
US3898340A (en) * 1970-04-15 1975-08-05 Bayer Ag Aryliminothiazolidine compositions and methods
CH533420A (de) * 1970-06-23 1973-02-15 Agripat Sa Mittel zur Regulierung des Pflanzenwachstums und zur Erhöhung des Zuckergehaltes in Zuckerrohr
US4029803A (en) * 1976-05-03 1977-06-14 Merck & Co., Inc. Method of treatment with 2-iminothiazolidines and thiazolines
DE2655369A1 (de) * 1976-12-03 1978-06-08 Schering Ag 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung
HU180240B (en) * 1978-04-21 1983-02-28 Gyogyszerkutato Intezet Process for producing new,substituted 1,3-diaryl-2-iminoimidasolidines and 2-imino-hexahydro-pyrimidines
US4348393A (en) * 1978-06-09 1982-09-07 Delalande S.A. N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones
JPS59227870A (ja) * 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規２−グアニジノチアゾリン誘導体ならびにその製造法

Also Published As

Publication number Publication date
PH20995A (en) 1987-06-18
ES551480A0 (es) 1987-01-16
CA1246086A (en) 1988-12-06
SU1366058A3 (ru) 1988-01-07
JPH0466478B2 (pl) 1992-10-23
AT394555B (de) 1992-05-11
PL144821B1 (en) 1988-07-30
PL145084B1 (en) 1988-08-31
GR851006B (pl) 1985-11-25
DE3514843C2 (pl) 1992-11-05
CS304985A2 (en) 1987-07-16
HUT37928A (en) 1986-03-28
US4665083A (en) 1987-05-12
FR2563519B1 (fr) 1988-06-10
BE902249A (fr) 1985-10-22
SE8501988L (sv) 1985-10-26
DD231790A5 (de) 1986-01-08
ES8701741A1 (es) 1986-12-16
PL144860B1 (en) 1988-07-30
FI82454B (fi) 1990-11-30
IT8520482A0 (it) 1985-04-24
ATA124285A (de) 1991-10-15
HU191408B (en) 1987-02-27
DE3514843A1 (de) 1985-10-31
GB8510457D0 (en) 1985-05-30
FI82454C (fi) 1991-03-11
ES551481A0 (es) 1986-12-16
IT1208532B (it) 1989-07-10
GB2159814B (en) 1987-09-16
FI851606A0 (fi) 1985-04-23
SU1375132A3 (ru) 1988-02-15
CH664564A5 (de) 1988-03-15
JPS6127974A (ja) 1986-02-07
SE8501988D0 (sv) 1985-04-24
NO851638L (no) 1985-10-28
PL253089A1 (en) 1985-12-17
DK183585D0 (da) 1985-04-24
NL8501184A (nl) 1985-11-18
SE464813B (sv) 1991-06-17
ES542469A0 (es) 1986-07-16
SU1549480A3 (ru) 1990-03-07
NO164417B (no) 1990-06-25
FR2563519A1 (fr) 1985-10-31
GB2159814A (en) 1985-12-11
FI851606L (fi) 1985-10-26
ES8702391A1 (es) 1987-01-16
PT80336A (en) 1985-05-01
PT80336B (pt) 1987-06-17
CS255884B2 (en) 1988-03-15
DK183585A (da) 1985-10-26
ES8608499A1 (es) 1986-07-16

Similar Documents

Publication Publication Date Title
NO166327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO158021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat.
NO871267D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO851400L (no) Fremgangsmaate ved fremstilling av fysiologisk aktive polypeptider.
NO164165C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO874869D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO810675L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO883750L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO159528C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO161177C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere.
NO160205C (no) Fremgangsmaate ved fremstilling av silibininderivater.
NO164417C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater.
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
NO164416C (no) Analogiremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.